NCT04976660: A trial that was reported late by Tarus Therapeutics, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04976660 |
|---|---|
| Title | Phase I/II First-in-Human Study of TT-4 as a Single Agent in Participants With Advanced Selected Solid Tumors |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Dec. 15, 2022 |
| Completion date | June 1, 2023 |
| Required reporting date | May 31, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 19, 2025 |
| Days late | 290 |